"The challenge for states
[is], particularly with their budget crisis, the ability to launch big new
infrastructures and big new investments is pretty limited, so we're thinking of
strategies that would begin to address affordability in ways that are easier
for state to implement."
— Trish Riley, executive director of the National Academy for
State Health Policy, spoke with AIS’s RADAR
on Drug Benefits about how states are continuing to work to lower
drug costs, even amid the pandemic.
No comments:
Post a Comment